Research Article
Disturbances of Modulating Molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA Expressions in the Orbital Tissue from Patients with Severe Graves’ Ophthalmopathy
Table 2
Immunohistochemical evaluation grading score for TCR and CD3 of each specimen.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Legend for Table 2: Immunohistochemistry scores are as follows: 0: less than 10% positive in 10 representative high power fields (HPF), 1: 11%–50% positive cells in 10 HPF, 2: more than 50% positive cells in 10 HPF. Immunohistochemistry was done using DAB chromogen (brown staining). |